Back
BNP Paribas Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
61
BNPQY
BNP Paribas
Last Price:
$38.23
Seasonality Move:
0.78%
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
$51.00
Seasonality Move:
12.51%
Buy
61
BNP Paribas (BNPQY)
is a Buy
Is BNP Paribas a Buy, Sell or Hold?
-
The current BNP Paribas [BNPQY] share price is $38.10. The Score for BNPQY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
BNPQY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $50.31. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BNPQY Stock Price Chart
What is BNP Paribas's stock price today?
-
The BNP Paribas share price today is $38.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNPQY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $50.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
BNPQY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 43.42 | Sell |
Chaikin Money Flow: | 670045 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.83 - 43.63) | Sell |
Bollinger Bands (100): | (30.26 - 39.5) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -12.43 | Sell |
Relative Strength Index (14 RSI): | 25.41 | Sell |
Chaikin Money Flow: | -2337291 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.24 - 93.24) | Sell |
Bollinger Bands (100): | (85.21 - 128.11) | Sell |
BNPQY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.89 | Sell |
20-day SMA: | 41.36 | Sell |
50-day SMA: | 38.83 | Sell |
200-day SMA: | 34.48 | Buy |
8-day EMA: | 38.73 | Sell |
20-day EMA: | 39.91 | Sell |
50-day EMA: | 38.7 | Sell |
200-day EMA: | 35.28 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.64 | Sell |
20-day SMA: | 68.68 | Sell |
50-day SMA: | 92.51 | Sell |
200-day SMA: | 121.01 | Sell |
8-day EMA: | 56.28 | Sell |
20-day EMA: | 67.87 | Sell |
50-day EMA: | 86.24 | Sell |
200-day EMA: | 111.03 | Sell |
BNP Paribas Earnings Growth & BNPQY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.35 per share, a decrease next quarter of $0.47 per share, an increase this year of $4.58 per share, and an increase next year of $5.49 per share.
BNP Paribas Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |